Vitamin E supplementation could reduce the risk
of malformations to children born to mothers with pre-gestational obesity. This
is the conclusion of a study published in the journal Antioxidants, conducted and
led by researchers from the Metabolism and Vascular Function Group (MET-VASC)
at CEU USP, in collaboration with Harvard University, Boston (USA). Researchers from the Universities of Valencia, Veracruz (Mexico) and Havana
(Cuba) also participated with doctors Marta Viana, Martín Alcalá, Isabel Sánchez-Vera
and Esther Carrera and pre-doctoral researcher Fabiola Álvarez, from CEU USP,
and Dr. Loeken, from Harvard University.
The research shows that obesity prior to
gestation increases the appearance of congenital malformations, mainly those
related to the development of the neural tube. Extrapolated to humans, this
type of malformation prevents gestation from reaching full term and, in doing so, causes pathologies such as
meningocele or spina bifida in the newborn. "We observed that 25% of the
embryos of obese mothers had severe malformations, while this percentage was
reduced to 11% in the embryos of obese mothers supplemented with vitamin E, consistent
with findings in studies on pregnancies of thin rats", states Dr
Sánchez-Vera.
This study focuses on oxidative stress as the
origin of the appearance of these malformations. "Our body physiologically
generates highly reactive chemical species with pro-oxidant characteristics. To
keep their level under control and prevent them from damaging large molecules,
such as proteins, lipids or even DNA, we have a series of enzymes and
antioxidant compounds that are responsible for maintaining the balance. If this
balance is lost in favor of oxidative species, we speak of oxidative
stress", explains Dr. Viana. She also stresses that "the problem is
that both obesity and pregnancy are situations that, in isolation, produce
oxidative stress. Therefore, when combined, an additional effect is produced
that dewfeats the mother's antioxidant defenses, causing this damage to reach
the embryo in formation".
This research reveals the key role of the major
endogenous water-soluble endogenous antioxidant, glutathione, which we all have
in our bodies. In mothers with pregestational obesity, this antioxidant is
consumed to cope with oxidative damage. Therefore, there is a smaller amount
available both for the embryo itself, and also for it to develop its spine or
brain correctly in the early stages of gestation. Treatment with an exogenous
antioxidant, vitamin E, provides protection against oxidation to both the
mother and the embryo, thereby preventing glutathione from being depleted and
allowing normal development of the embryo's structures in the first weeks of
pregnancy.
According to Dr. Alcalá, "the loss of
glutathione as a basis for the appearance of malformations had already been
studied in other situations such as smoking, ionizing radiation or the use of
some drugs such as valproate. This study, however, in addition to being the
first time in which it is related to maternal obesity, provides a simple
solution through vitamin E supplementation". Dr. Carrera and Fabiola
Álvarez point out that "several clinical trials have attempted to analyze
the potential beneficial effect of antioxidants to prevent complications
associated with pregnancy, but the results have never been particularly
enlightening. It is also worth noting that practically none of the previous
trials separately analyzed the effect of pregestational obesity in the mother,
where we believe the effect could be very beneficial".
Maternal obesity increases the risk of
comorbidities before, during and after gestation, both for the mother and the
fetus. Mothers with pre-pregnancy obesity may have fertility problems,
increased risk of spontaneous and recurrent miscarriages, preeclampsia,
gestational diabetes, and complications during delivery. Newborns are also at
increased risk of shoulder dystocia, of being born with inadequate birth weight
and even of becoming obese individuals in the future. The results of the study
on animals highlight the importance for overweight and obese women planning to
become pregnant to work with their physicians, nutritionists, nurses and
pharmacists to lose weight. This study opens the door to reconsideration of
antioxidant supplementation in pregnant women at potential risk - thus ensuring
a sustainable and environmentally friendly production system, by reducing the
use of agrochemicals with consequent health benefits.